Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Future of PDSG?

Based on the following, any guesses as to what the BoD should be doing about PDSG(Crossflo) . Gloria only needed 120 days to make a decision....long overdue

Since the acquisition of our wholly-owned subsidiary PDSG in September 2008, we have provided 100% of PDSG’s operational funding amounting to approximately $8,200,000 through May 31, 2011. After restructuring measures initiated in October 2009 and continued through 2010, PDSG continues to remain unable to generate sufficient revenues to support its operations and remains entirely dependent on our funding. Should a sale of PDSG occur, it may be on distressed terms with only minimal consideration realized. P11

2
Aug 30, 2011 01:12PM
2
Aug 30, 2011 01:21PM
Share
New Message
Please login to post a reply